VF in the News

Penn’s Giant Cell Arteritis Fast-Track Program Provides Rapid Evaluation

The tricky part of giant cell arteritis (GCA) is the need for rapid evaluation, given the high risk of rapid vision loss and the importance of getting appropriate diagnostic tests, such as a temporal artery biopsy, soon after starting treatment. Unfortunately, there are not a lot of outpatient programs that…...

Read more

Open Study: Evaluation of Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis

Brief Summary: Primary Objective: To evaluate the efficacy of sarilumab in patients with giant cell arteritis (GCA) as assessed by the proportion of patients with sustained remission for sarilumab compared to placebo, in combination with a corticosteroid (CS) tapering course. Secondary Objective: To demonstrate the efficacy of sarilumab in patients…...

Read more